Company: FCRS
Filing Date: 2025-09-26
Form Type: 424B4
Source: 0001213900-25-092098
Chunk: 154

Company: FutureCrest Acquisition Corp.
Filing Date: 2025-09-26
Form: 424B4
Chunk 154
---
 will be no associated material exposure to interest rate risk. 99 Related Party Transactions On June 9, 2025, our sponsor paid $25,000, or approximately $0.0045 per share, to cover certain of our offering costs and expenses in exchange for 6,325,000 founder shares. In August 2025, we issued, in a share capitalization, an additional 862,500 Class B ordinary shares to our sponsor, resulting on our sponsor holding 7,187,500 founder shares, at approximately, $0.0035 per share. The number of founder shares outstanding was determined based on the expectation that the total size of this offering would be a maximum of 28,750,000 units if the underwriters’ over -allotmentoption is exercised in full, and therefore that such founder shares would represent 20% of the outstanding shares after this offering. Our public shareholders may incur material dilution due to such anti -dilutionadjustments that result in the issuance of Class A ordinary shares on a greater than one -to -onebasis upon conversion. Up to 937,500 of the founder shares will be surrendered for no consideration depending on the extent to which the underwriters’ over -allotmentoption is exercised. Our sponsor and Cantor Fitzgerald & Co. have committed, pursuant to written agreements, to purchase an aggregate of 3,500,000 private placement warrants, each exercisable to purchase one Class A ordinary share at $11.50 per share, at a price of $2.00 per warrant, or $7,000,000 in the aggregate, in a private placement that will close simultaneously with the closing of this offering. Of those 3,500,000 private placement warrants, our sponsor has agreed to purchase 2,250,000 warrants and Cantor Fitzgerald & Co. has agreed to purchase 1,250,000 warrants. The private placement warrants will also be worthless if we do not complete our initial business combination. The private placement warrants will be identical to the warrants sold in this offering except that, so long as they are held by our sponsor or its permitted transferees, the private placement warrants (i) may not (including the Class A ordinary shares issuable upon exercise of these warrants), subject to certain limited exceptions, be transferred, assigned or sold by the holders until 30 days after the completion of our initial business combination, (ii) will be entitled to registration rights and (iii) with respect to private placement